SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-22-002221
Filing Date
2022-05-27
Accepted
2022-05-27 16:30:30
Documents
10
Period of Report
2022-05-27

Document Format Files

Seq Description Document Type Size
1 6-K zk2227915.htm 6-K 11171
2 PROXY STATEMENT exhibit_1.htm EX-99 281255
3 PROXY CARD exhibit_2.htm EX-99 33768
4 PROXY CARD AND VOTING INSTRUCTION CARD FOR HOLDERS OF AMERICAN DEPOSITARY SHARES exhibit_3.htm EX-99 60822
5 image0.jpg GRAPHIC 14235
6 image6.jpg GRAPHIC 1430
7 img01.jpg GRAPHIC 17779
8 img02.jpg GRAPHIC 64422
9 img03.jpg GRAPHIC 55359
10 img04.jpg GRAPHIC 58715
  Complete submission text file 0001178913-22-002221.txt   680585
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 22978107
SIC: 2834 Pharmaceutical Preparations